cuprymina
a.c.o.m. - advanced center oncology - ram (64cu) kloridu - radjonuklidi imaging - various diagnostic radiopharmaceuticals - cuprymina huwa prekursur radjofarmaċewtiku. mhuwiex maħsub għal użu dirett f'pazjenti. dan il-prodott mediċinali għandu jintuża biss għar-radjutikkettar ta 'molekuli li jġorru, li ġew żviluppati u awtorizzati speċifikament għal radjutikkettjar b'din ir-radjonuklide.
eucreas
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
faslodex
astrazeneca ab - fulvestrant - neoplażmi tas-sider - endokrinali it-terapija, anti-estroġeni - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. , fil - pre- jew perimenopausal-nisa, il-kombinazzjoni tat-trattament bil-palbociclib għandu jkun ikkombinat ma ' ormon luteinizing releasing hormone (lhrh) agonist.
fasturtec
sanofi winthrop industrie - rasburicase - iperurċemija - il-prodotti terapewtiċi l-oħra kollha - it-trattament u l-profilassi ta ' hyperuricaemia akuta, sabiex jiġi evitat falliment renali akuta, fl-adulti, tfal u adolexxenti (età 0 sa 17 snin) ma malignancy ħematoloġiċi mal-piż tumur għolja u f'riskju tumur rapida lysis jew jinxtorob fil bidu ta ' l-chemotherapy.
forsteo
eli lilly nederland b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - homeostasi tal-kalċju - trattament ta 'l-osteoporożi f'nisa wara l-menopawża u fl-irġiel b'riskju akbar ta' ksur. f'nisa wara l-menopawża, intwera tnaqqis sinifikanti fl-inċidenza ta 'ksur vertebrali u mhux vertebrali iżda mhux fratturi tal-ġenbejn. trattament ta 'osteoporożi assoċjat ma sostnut sistemika terapija bi glukokortikojdi f'nisa u l-irġiel f'riskju akbar ta' ksur.
hetlioz
vanda pharmaceuticals netherlands b.v. - tasimelteon - disturbi fl-irqad, rhythm circadian - psikolettiċi - hetlioz huwa indikat għall-kura ta 'mhux-24-hour sleep-wake disorder (mhux-24) f'adulti totalment għomja.
cardalis
ceva santé animale - benazepril hydrochloride, spironolactone - sistema kardjovaskulari - klieb - għat-trattament ta 'insuffiċjenza tal-qalb konġestiva kkawżata minn mard valvulari klementi deġenerattiv fil-klieb (b'appoġġ dijuretiku kif xieraq).
infanrix penta
glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), poliovirus (inactivated) (type 1 (mahoney strain), type 2 (mef-1 strain), type 3 (saukett strain)), hepatitis b surface antigen - hepatitis b; tetanus; immunization; whooping cough; poliomyelitis; diphtheria - vaċċini - infanrix penta huwa indikat għall-vaċċinazzjoni primarja u booster tat-trabi kontra diphtheria, tetanus, pertussis, epatite b u poliomyelitis.
palladia
zoetis belgium sa - toceranib - aġenti antineoplastiċi - klieb - it-trattament ta mhux resectable patnaik grad-ii (intermedju-grad) jew iii (grad għoli), l-rikorrenti, tal-ġilda mast-tumuri taċ-ċelluli fil-klieb.
porcilis pcv id
intervet international b.v. - Ċirovirus tal-porċini tat-tip 2 ta 'l-antiġen tat-tip subunit orf2 - immunologicals for suidae, inactivated viral vaccines - majjali - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection. to reduce loss of daily weight gain and mortality associated with pcv2 infection.